Aytu BioPharma, Inc. Financial Ratios — AYTU Stock

Profitability (USD)

	2013 Y	2014 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	08/31/2013	06/30/2014	08/31/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025	06/30/2026

Return on Common Equity (%)	- -	- -	- -	- -	-219.29	-319.61	-116.94	-264.55	-26.68	-50.12	-119.62	-40.76	-47.24	-58.1	-52.55
Return on Assets (%)	-513.69	-92.78	-1.03	-84.92	-132.52	-114.43	-56.51	-97.28	-14.49	-27.83	-53.95	-12.44	-12.45	-11.2	-12.44
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	66.34	62.65	56.01	43.98	69.92	70.03	44.49	54.08	62.04	75.26	69.04	63.95
EBITDA Margin (%)	-2,712.69	-10,604.89	-5,270.9	-2,870.37	-520.14	-449.88	-416.73	-192.88	-44.18	-44.25	-26.85	-3.27	11.18	11.92	-7.62
Operating Margin (%)	-2,995.09	-10,770.31	-5,748.9	-2,915.53	-554.28	-585.35	-487.53	-230.13	-64.86	-58.26	-37.35	-11.48	0.87	3.82	-14.44
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-30.54	164.47	- -
Pretax Margin (%)	-3,275.31	-10,847.61	-6,172.3	-2,959.45	-1,099.66	-698.58	-278.35	-370.64	-49.29	-88.42	-112.64	-15.88	-15.92	-20.71	-24.72
Profit Margin (%)	-3,275.31	-9,466.8	-6,172.3	-2,950.32	-1,099.66	-698.58	-278.35	-370.64	-49.29	-88.81	-112.53	-15.88	-24.31	-20.43	-24.76
Net Income to Common Margin (%)	-3,275.31	-9,466.8	-6,172.3	-2,950.32	-1,099.66	-698.58	-278.35	-370.64	-49.29	-88.81	-112.53	-15.88	-24.31	-20.43	-24.76
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	-219.29	-319.61	-116.94	-264.55	-26.68	-50.12	-119.62	-40.76	-47.24	-58.1	-52.55

Credit (USD)

Credit Ratios API ChatGPT

	2013 Y	2014 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	08/31/2013	06/30/2014	08/31/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025	06/30/2026

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	2	25	18	16	15	22	17
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	1	25	4	2	4	11	8
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	14	15	11	11	9
Total Debt/EBITDA	-2.1	- -	-0.59	- -	- -	- -	- -	- -	-0.16	-0.85	-0.7	-4.66	2.08	2.76	-3.88
Net Debt/EBITDA	-2.06	0.42	-0.54	0.98	0.6	0.06	0.46	0.78	3.86	0.86	0.05	1.89	-0.67	-1.15	2.12
Total Debt/EBIT	-1.9	- -	-0.54	- -	- -	- -	- -	- -	-0.11	-0.65	-0.5	-1.33	26.78	8.6	-2.05
Net Debt/EBIT	-1.86	0.42	-0.5	0.96	0.57	0.04	0.39	0.66	2.63	0.65	0.03	0.54	-8.63	-3.6	1.12
EBITDA to Interest Expense	-9.68	-137.19	-12.45	-65.34	-2.43	-5.72	-20.35	- -	- -	- -	- -	-0.71	1.44	2.14	-2.31
EBITDA-CapEx/Interest Expense	-9.68	-137.39	-12.45	-65.34	-2.84	-5.76	-20.45	- -	- -	- -	- -	-0.71	1.38	1.27	-2.33
EBIT to Interest Expense	-10.69	-139.33	-13.58	-66.37	-2.59	-7.44	-23.81	- -	- -	- -	- -	-2.48	0.11	0.69	-4.39
Interest Expense	- -	- -	- -	- -	5	3	1	- -	- -	- -	- -	5	5	4	2
Common Equity/Total Assets	-1,146.51	44.69	-816.05	85.87	41.43	26.67	63.74	20.41	61.98	51.78	32.2	28.84	23.47	15.27	33.59
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.76	0.13	32.23	37.38	39.24	57.44	25.8
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.75	0.11	22.85	26.41	25.39	26.72	17.4
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.47	0.07	10.38	10.78	9.21	8.77	8.67
Total Debt/Equity (%)	-89.77	- -	-68.87	- -	- -	- -	- -	- -	2.11	18.01	41.05	41.57	54.59	115.02	48.28
Total Debt/Capital (%)	-877.05	- -	-221.26	- -	- -	- -	- -	- -	2.07	15.26	29.1	29.36	35.31	53.49	32.56
Total Debt/Total Assets (%)	1,029.17	- -	562.04	- -	- -	- -	- -	- -	1.31	9.33	13.22	11.99	12.81	17.57	16.22
Net Debt to Equity	-88.09	-49.16	-63.73	-47.09	-79.86	-20.06	-52.24	-155.82	-49.57	-18.08	-2.65	-16.83	-17.6	-48.18	-26.3
Net Debt/Capital (%)	-739.31	-96.7	-175.68	-88.98	-396.55	-25.09	-109.37	279.15	-96.24	-22.06	-2.72	-20.24	-21.35	-92.96	-35.68
EBITDA	- -	-6	- -	-8	-13	-14	-15	-14	-12	-29	-26	-4	7	8	-4
EBITDA-CapEx	- -	-6	- -	-8	-16	-15	-15	-14	-12	-29	-26	-4	7	5	-4
Operating Income (Loss)	- -	-6	- -	-8	-14	-19	-18	-17	-18	-38	-36	-12	1	3	-8

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2013 Y	2014 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	08/31/2013	06/30/2014	08/31/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025	06/30/2026

Cash Ratio	0.02	0.43	0.05	4.98	0.9	0.22	2.07	2.06	1.67	0.45	0.3	0.33	0.32	0.49	0.48
Current Ratio	0.02	0.54	0.05	5.44	1	0.84	2.79	2.87	2.62	0.96	0.93	1.03	0.99	1.26	1.13
Quick Ratio	0.02	0.43	0.05	5.08	0.92	0.37	2.24	2.38	1.87	0.71	0.64	0.75	0.7	0.98	0.9
CFO/Avg Current Liab	-0.37	-1.77	-0.01	-8.68	-1.84	-2.02	-4.55	-3.16	-1.66	-0.38	-0.33	-0.08	-0.02	-0.03	0.06
Common Equity/Total Assets	-1,146.51	44.69	-816.05	85.87	41.43	26.67	63.74	20.41	61.98	51.78	32.2	28.84	23.47	15.27	33.59
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.76	0.13	32.23	37.38	39.24	57.44	25.8
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.75	0.11	22.85	26.41	25.39	26.72	17.4
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.47	0.07	10.38	10.78	9.21	8.77	8.67
Total Debt/Equity (%)	-89.77	- -	-68.87	- -	- -	- -	- -	- -	2.11	18.01	41.05	41.57	54.59	115.02	48.28
Total Debt/Capital (%)	-877.05	- -	-221.26	- -	- -	- -	- -	- -	2.07	15.26	29.1	29.36	35.31	53.49	32.56
Total Debt/Total Assets (%)	1,029.17	- -	562.04	- -	- -	- -	- -	- -	1.31	9.33	13.22	11.99	12.81	17.57	16.22
CFO/Total Liabilities	-31.28	-82.78	-76.67	-258.25	-74.75	-125.74	-208.76	-50.05	-48.69	-20.27	-30.89	-5.28	-1.54	-1.84	4.71
CFO/CapEx	- -	-591.74	- -	- -	-4.73	-123.91	-213.37	-231.11	- -	- -	- -	- -	-4.22	-0.6	113.14
Altman's Z-Score	-114.78	-10.26	-204.78	9.46	-9.63	-41.98	-15.66	-11.12	-0.04	-2.11	-6.24	-4.55	-5.69	-4.44	-6.85

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2013 Y	2014 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	08/31/2013	06/30/2014	08/31/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025	06/30/2026

Accounts Receivable Turnover	- -	- -	- -	3.33	16.04	9.33	6.61	6.31	7.49	3.88	3.88	4.24	2.48	2.43	2.13
Days Sales Outstanding	- -	- -	- -	109.49	22.75	39.11	55.19	57.83	48.7	94.01	94.18	86.07	146.89	150.33	170.97
Inventory Turnover	- -	- -	- -	4.47	3.39	1.54	1.55	1.58	1.45	2.77	3.27	3.57	1.34	1.74	2.27
Days Inventory Outstanding	- -	- -	- -	81.7	107.57	236.52	235.96	230.32	252.1	131.94	111.79	102.26	273.1	209.35	160.88
Accounts Payable Turnover	- -	- -	- -	0.21	0.82	0.97	0.96	1.08	2.45	2.77	2.57	3.43	1.37	1.9	1.48
Accounts Payable Turnover Days	- -	- -	- -	1,710.78	445.13	376.03	381.3	337.02	149.27	131.82	141.9	106.53	266.79	192.35	246.88
Cash Conversion Cycle	- -	- -	- -	-1,519.59	-314.8	-100.4	-90.15	-48.87	151.53	94.12	64.08	81.8	153.19	167.34	84.98
Inventory to Cash Days	- -	- -	- -	27.8	-84.82	-197.42	-180.77	-172.49	-203.4	-37.92	-17.6	-16.2	-126.21	-59.02	10.09
Inventories	- -	- -	- -	- -	1	1	1	1	10	16	11	12	12	11	7
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	2	1	- -	1	1
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	2	3	6	1	2
Finished Goods	- -	- -	- -	- -	1	1	1	1	10	11	7	8	6	9	3
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2013 Y	2014 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	08/31/2013	06/30/2014	08/31/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025	06/30/2026

Market Capitalization	- -	- -	- -	62	17	10	9	33	179	138	27	9	17	20	23
- Cash & Cash Equivalents	- -	3	- -	7	8	1	7	11	48	50	19	23	20	31	26
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	2	25	18	16	15	22	17
Enterprise Value	- -	-3	- -	55	8	9	2	22	133	113	25	2	13	10	14
Total Capital	- -	5	- -	16	10	4	13	7	97	162	62	56	43	41	52
Total Debt/Capital (%)	-877.05	- -	-221.26	- -	- -	- -	- -	- -	2.07	15.26	29.1	29.36	35.31	53.49	32.56
Total Debt / EV	1.02	- -	1.08	- -	- -	- -	- -	- -	0.02	0.22	0.71	7.43	1.2	2.09	1.23
EV/Sales	55.8	312.81	28.67	209.83	3.17	2.77	0.63	3.02	4.8	1.72	0.26	0.02	0.19	0.16	0.24
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.72	1.32	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	22.24	4.11	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.66	5.54	2.66
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.49	2.04	2.65
Diluted Market Cap	19	21	18	62	17	10	3	15	64	84	20	5	16	14	26
Diluted Enterprise Value	19	18	18	55	9	9	-4	4	18	59	19	-1	11	5	17
EV per Share	- -	2,048,169.1	- -	3,923,561.85	176,670.61	43,305.2	258.49	252.06	210.77	82.11	13.19	0.4	2.1	1.16	1.29
TTM Sales	- -	- -	- -	- -	3	3	4	7	28	66	97	107	65	66	58
TTM EBITDA	- -	-6	- -	-8	-13	-14	-15	-14	-12	-29	-26	-4	7	8	-4
TTM Operating Income	- -	-6	- -	-8	-14	-19	-18	-17	-18	-38	-36	-12	1	3	-8
TTM Cash Flow to Firm	- -	-5	- -	-7	-5	-11	-15	-14	-28	-26	-29	- -	5	2	5
TTM Free Cash Flow to Firm	- -	-5	- -	-7	-3	-11	-15	-14	-28	-26	-29	- -	5	5	5

Multiples (USD)

Valuation Multiples API ChatGPT

	2013 Y	2014 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	08/31/2013	06/30/2014	08/31/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025	06/30/2026

Price/Free Cash Flow	-496.81	-3.84	-462.58	-9.39	-2.05	-0.71	-0.22	-1.07	-2.26	-3.23	-0.7	-1.04	-15.27	10.6	8
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	22.24	4.11	- -
Enterprise Value	- -	-3	- -	55	8	9	2	22	133	113	25	2	13	10	14
Low Price	2,341,463.54	2,341,463.54	1,990,243.9	1,873,170.73	259,200	40,800	920	136	68	94.6	9	1.38	1.52	0.95	1.65
EV/Sales	55.8	312.81	28.67	209.83	3.17	2.77	0.63	3.02	4.8	1.72	0.26	0.02	0.19	0.16	0.24
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.72	1.32	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-854.02	-5.77	-514.71	-5.22	-3.88	-1.3	-3.86	-0.64	-4.11	-2.58	-0.53	-0.8	-0.91	-0.86	-2.05
Price/Earnings High	-1,143.81	-16.05	-1,451.01	-20.58	-7.44	-3.66	-15.68	-2.24	-9.92	-4.45	-1.4	-3.17	-1.22	-1.37	-2.65
Price/Earnings Low	-326.8	-3.78	-290.2	-3.4	-0.42	-0.37	-0.3	-0.2	-1.13	-1.36	-0.12	-0.27	-0.53	-0.44	-1.43
Price/Book Value	- -	- -	- -	3.99	1.71	2.43	0.7	4.68	1.88	1	0.6	0.22	0.63	1.03	0.65
Price/Book Value Average	- -	- -	- -	2.58	10.85	7.3	7.89	5.52	1.64	1.79	1.71	0.57	0.56	0.88	0.72
Price/Book Value High	- -	- -	- -	10.18	20.8	20.6	32.08	19.3	3.96	3.1	4.52	2.27	0.75	1.4	0.93
Price/Book Value Low	- -	- -	- -	1.68	1.18	2.1	0.61	1.68	0.45	0.95	0.39	0.19	0.33	0.45	0.5
Price/Tangible Book Value	- -	- -	- -	10.66	-4.67	-1.33	4.53	-2.76	9.89	-10.05	-1.01	-0.45	-0.71	-0.84	-3.77
Price/Tangible Book Value Average	- -	- -	- -	6.89	-29.65	-3.99	51.47	-3.26	8.62	-17.99	-2.88	-1.15	-0.63	-0.72	-4.14
Price/Tangible Book Value High	- -	- -	- -	27.21	-56.84	-11.26	209.24	-11.4	20.82	-31.11	-7.61	-4.56	-0.85	-1.14	-5.38
Price/Tangible Book Value Low	- -	- -	- -	4.49	-3.23	-1.15	4.01	-0.99	2.37	-9.49	-0.66	-0.39	-0.37	-0.37	-2.89
Price/Sales	10,703.83	357.6	17,912.2	237.92	6.72	3.02	0.95	2.01	2.32	1.28	0.21	0.05	0.25	0.21	0.46
Price/Sales Average	27,971.82	546.48	31,769.27	153.89	42.7	9.06	10.74	2.37	2.02	2.29	0.6	0.13	0.22	0.18	0.51
Price/Sales High	37,463.41	1,519.81	89,560.98	607.32	81.85	25.57	43.64	8.31	4.89	3.95	1.58	0.5	0.3	0.28	0.66
Price/Sales Low	10,703.83	357.6	17,912.2	100.18	4.65	2.61	0.84	0.72	0.56	1.21	0.14	0.04	0.13	0.09	0.35
Price/Cash Flow	-496.81	-3.83	-462.58	-9.39	-1.62	-0.7	-0.22	-1.07	-2.26	-3.23	-0.7	-1.04	-11.65	-7.07	8.07
Price/Cash Flow Average	-1,298.29	-5.85	-820.45	-6.07	-10.27	-2.11	-2.47	-1.26	-1.97	-5.78	-2	-2.67	-10.35	-6.05	8.88
Price/Cash Flow High	-1,738.83	-16.28	-2,312.92	-23.96	-19.68	-5.96	-10.02	-4.4	-4.76	-10	-5.29	-10.55	-13.96	-9.6	11.53
Price/Cash Flow Low	-496.81	-3.83	-462.58	-3.95	-1.12	-0.61	-0.19	-0.38	-0.54	-3.05	-0.46	-0.9	-6.06	-3.08	6.2
Price/Free Cash Flow Average	-1,298.29	-5.86	-820.45	-6.07	-13.02	-2.13	-2.48	-1.26	-1.97	-5.78	-2	-2.67	-13.56	9.07	8.81
Price/Free Cash Flow High	-1,738.83	-16.31	-2,312.92	-23.96	-24.96	-6.01	-10.07	-4.41	-4.76	-10	-5.29	-10.55	-18.3	14.4	11.43
Price/Free Cash Flow Low	-496.81	-3.84	-462.58	-3.95	-1.42	-0.61	-0.19	-0.38	-0.54	-3.05	-0.46	-0.9	-7.95	4.62	6.14
EV/Sales Average	55.8	501.69	28.67	125.8	39.55	8.81	27.03	3.83	3.97	3.38	0.77	0.15	0.16	0.11	0.28
EV/Sales High	55.8	1,475.02	28.67	579.23	78.71	25.33	115.76	17.18	11.95	6.11	2.06	0.77	0.25	0.26	0.41
EV/Sales Low	55.8	312.81	28.67	72.09	1.51	2.36	0.34	0.12	- -	1.6	0.17	0.01	0.06	- -	0.15
EV/EBITDA Average	-2.06	0.42	-0.54	-4.38	-7.6	-1.96	-6.49	-1.99	-8.98	-7.63	-2.88	-4.54	1.46	0.96	-3.68
EV/EBITDA High	-2.06	0.42	-0.54	-20.18	-15.13	-5.63	-27.78	-8.91	-27.05	-13.82	-7.67	-23.55	2.2	2.2	-5.4
EV/EBITDA Low	-2.06	0.42	-0.54	-2.51	-0.29	-0.52	-0.08	-0.06	0.27	-3.62	-0.62	-0.28	0.58	-0.08	-1.92
EV/EBIT Average	-1.86	0.42	-0.5	-4.31	-7.14	-1.51	-5.54	-1.67	-6.12	-5.79	-2.07	-1.29	18.79	3	-1.94
EV/EBIT High	-1.86	0.42	-0.5	-19.87	-14.2	-4.33	-23.74	-7.46	-18.42	-10.49	-5.51	-6.71	28.37	6.87	-2.85
EV/EBIT Low	-1.86	0.42	-0.5	-2.47	-0.27	-0.4	-0.07	-0.05	0.18	-2.75	-0.45	-0.08	7.44	-0.24	-1.01
Last Price	2,341,463.54	2,341,463.54	1,990,243.9	4,448,780.49	374,400	47,200	1,040	378	284	100.2	13.8	1.6	2.92	2.18	2.15
High Price	8,195,121.95	9,951,220	9,951,220	11,356,098	4,560,000	400,000	48,000	1,560	598	310	103.8	16.2	3.5	2.96	3.07
Enterprise Value Average	- -	-3	- -	33	101	28	99	28	110	222	75	16	11	8	16
Enterprise Value High	- -	-3	- -	152	202	82	424	126	330	401	199	83	16	17	24
Enterprise Value Low	- -	-3	- -	19	4	8	1	1	-3	105	16	1	4	-1	8

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	1	1	2	6	6	9	11
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	3	6	6	12
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	3	6	6	12
Revenue per Share	218.75	6,547.67	111.11	18,698.71	55,708.85	15,640.78	1,099.8	187.84	122.29	78.38	65.77	32.16	11.77	10.57	4.67
EBITDA per Share	-5,934	-694,373.11	-5,856.56	-536,722.71	-289,764.13	-70,365.35	-4,583.22	-362.3	-54.02	-34.68	-17.66	-1.05	1.32	1.26	-0.36
Operating Income per Share	-6,551.75	-705,203.78	-6,387.67	-545,165.71	-308,781.28	-91,553.12	-5,361.84	-432.28	-79.31	-45.67	-24.56	-3.69	0.1	0.4	-0.67
Basic EPS, GAAP	-7,164.75	-619,854.44	-6,858.11	-551,671.71	-612,610.52	-109,263.61	-3,061.26	-696.19	-60.28	-69.61	-74.01	-5.11	-2.86	-2.16	-1.16
Basic EPS from Cont Ops	-7,164.75	-619,854.44	-6,858.11	-551,671.71	-612,610.52	-109,263.61	-3,061.26	-696.19	-60.28	-69.61	-74.01	-5.11	-2.26	-2.26	-1.16
Diluted EPS, GAAP	-7,164.75	-619,854.44	-6,858.11	-551,671.71	-612,610.52	-109,263.61	-3,061.26	-696.19	-60.28	-69.61	-74.01	-5.11	-2.86	-2.16	-1.16
Diluted EPS from Cont Ops	-7,164.75	-619,854.44	-6,858.11	-551,671.71	-612,610.52	-109,263.61	-3,061.26	-696.19	-60.28	-69.61	-74.01	-5.11	-2.26	-2.26	-1.16
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-4,713	-611,329.11	-4,302.44	-473,872.43	-231,683.67	-67,134.23	-4,789.76	-354.91	-125.57	-31.01	-19.61	-1.54	-0.25	-0.31	0.27
Free Cash Flow per Basic Share	-4,713	-612,362.22	-4,302.44	-473,872.43	-280,660.46	-67,676.02	-4,812.21	-356.44	-125.57	-31.01	-19.61	-1.54	-0.31	-0.82	0.26
Cash & Equivalents per Share	- -	- -	- -	525,218.64	197,729.39	3,894.8	781.51	125.95	76.42	36.12	10.04	4.17	3.35	3.45	2.45
Book Value per Share	- -	- -	- -	1,115,460.86	219,244.63	19,416.58	1,496.1	80.82	151.01	100.08	22.97	7.13	4.64	2.11	3.29
Tangible Book Value per Share	- -	- -	- -	417,380.5	-80,220.15	-35,532.62	229.4	-136.79	28.72	-9.97	-13.65	-3.55	-4.14	-2.59	-0.57

Aytu BioPharma, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)